Trillium Closes US$150 Million Public Offering of Common Shares Sep 16, 2020 04:05PM
Trillium Therapeutics (TRIL) Prices 10M Share Common Offering at $13/Sh Sep 11, 2020 05:51AM
Trillium Announces Pricing of US$130 Million Public Offering of Common Shares Sep 10, 2020 08:00PM
Trillium Therapeutics to Present at Upcoming Investor Conferences Sep 27, 2018 07:00AM
Trillium Therapeutics (TRIL) Undervaluation is 'Unwarranted' - Ladenburg Thalmann Jun 29, 2018 09:13AM


Sep 14, 2017 07:00AM Trillium Therapeutics to Present at Investor and Scientific Conferences in September
Jun 28, 2017 03:45PM Trillium Announces Partial Exercise of Over-Allotment Option
Jun 8, 2017 09:17AM Trillium Therapeutics (TRIL): Trial Expansions Encouraging - Ladenburg
Jun 1, 2017 04:10PM Trillium Closes US$30 Million Public Offering of Common Shares and Series II Non-Voting Convertible First Preferred Shares
May 26, 2017 08:32AM Trillium Therapeutics (TRIL) Prices 2.75M Shares at $5, Prices 3.25M Convertible Preferred Shares
May 26, 2017 08:30AM Trillium Announces Pricing of US$30.0 Million Public Offering of Common Shares and Series II Non-Voting Convertible First Preference Shares
May 25, 2017 04:03PM Trillium Therapeutics (TRIL) Plans Offering of Common Stock and Series II Non-Voting Convertible First Preferred Shares
May 25, 2017 04:01PM Trillium Announces Proposed Public Offering
Aug 23, 2016 07:00AM Trillium Therapeutics to Present at Investor and Scientific Conferences in September
Aug 3, 2016 10:41AM Notable Analyst Rating Changes 8/3: (ZNGA) (NMBL) (AVD) Upgraded; (CSIQ) (EQR) (EMR) Downgraded
Aug 3, 2016 07:08AM Ladenburg Thalmann Starts Trillium Therapeutics (TRIL) at Buy